Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData Read more
Panel Discussion: Future-ready formulations: Addressing the challenges of special population Read more
Panel Discussion: Topical and transdermal drug delivery: The rise of non-invasive therapies Read more
Panel Discussion: Biologics and biosimilars: The next leap in patient-centric drug development Read more